Alpha Teknova, Inc.

TKNO Biotech & pharma

Makes reagents for life sciences research and diagnostics.

Jun 2026Revenue $43.7M/yrExpenses $59.5M/yr
Fell below break-even Jun 2021Cash runway ≈ 2.4 years from Jun 2026
Figures by year

When will Alpha Teknova be profitable again?

Its expenses passed its revenue in Jun 2021. In the 12 months to Jun 2026, revenue was $43.7M and expenses $59.5M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$40.5M$57.5M−$17.0M
Dec 2024$37.7M$63.9M−$26.1M
Dec 2023$36.7M$72.2M−$35.6M
Dec 2022$41.4M$91.1M−$49.7M
Dec 2021$36.9M$48.9M−$12.0M
Dec 2020$31.3M$26.6M$4.66M